Log In Sign up
The largest database of trusted experimental protocols

Hiv19 27

Manufactured by Immudex
Visit Supplier
Sourced in Denmark

HIV19–27 is a synthetic peptide that corresponds to a specific region of the HIV-1 p24 protein. It is used in research applications involving the study of HIV-1 immunology and vaccine development.

Automatically generated - may contain errors

Lab products found in correlation

Dextramer rpe, by Immudex (2 mentions) Facsaria cell sorter, by BD (2 mentions) Anti cd8 fitc, by Immudex (1 mentions) Anti cd8 fitc, by ProImmune (1 mentions)

2 protocols using hiv19 27

1

GPC3 and HIV Epitope Screening by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stained with HLA-A*02:01 Dextramer-RPE [GPC3144–152 (FVGEFFTDV) or HIV19–27 (TLNAWVKVV); Immudex, Copenhagen, Denmark] and HLA-A*24:02 Dextramer-RPE [GPC3298–306 (EYILSLEEL) or HIV583–591 (RYLKDQQLL); Immudex] for 10 min at room temperature and with anti-CD8-FITC (ProImmune) for 20 min at 4°C. Flow cytometry was performed using a FACSAria cell sorter (BD Biosciences, San Jose, CA, USA) as described previously.43 (link)
Tsuchiya N., Hosono A., Yoshikawa T., Shoda K., Nosaka K., Shimomura M., Hara J., Nitani C., Manabe A., Yoshihara H., Hosoya Y., Kaneda H., Kinoshita Y., Kohashi K., Yoshimura K., Fujinami N., Saito K., Mizuno S, & Nakatsura T. (2017). Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors. Oncoimmunology, 7(1), e1377872.
+ Open protocol
+ Expand
2

GPC3 and HIV Peptide Dextramer Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stained with HLA-A*02:01 Dextramer-RPE (GPC3 144–152 [FVGEFFTDV], HIV19–27 [TLNAWVKVV]; Immudex, Copenhagen, Denmark) and HLA-A*24:02 Dextramer-RPE (GPC3 298–306 [EYILSLEEL], HIV583–591 [RYLKDQQLL]; Immudex) for 10 min at room temperature and anti-CD8-FITC (ProImmune) for 20 min at 4°C. Flow cytometry was performed using a FACSAria cell sorter (BD Biosciences).
Tsuchiya N., Yoshikawa T., Fujinami N., Saito K., Mizuno S., Sawada Y., Endo I, & Nakatsura T. (2017). Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma. Oncoimmunology, 6(10), e1346764.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!